August 2012
-
Oyster Point Pharma has announced that the Phase 2b PEARL study of its OC-02 intranasal nicotinic acetylcholine receptor (nAChR) agonist for the treatment of dry eye disease demonstrated a statistically significant increase in production of… Read more . . .
-
Inhalation Sciences subsidiary Ziccum has been awarded a grant of 500,000 SEK (~ €48,600) by the EU’s Horizon 2020 research and innovation project for scale up of its LaminarPace spray drying technology, the company said.… Read more . . .
-
TFF Pharmaceuticals said that it has received a notice of allowance for US Patent Application No. 12/778,795, titled, “Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing,” which covers technology related to the… Read more . . .
-
Glenmark Pharmaceuticals has announced that it will receive an unspecified amount up front, plus regulatory and commercial milestone payments, from Seqirus for the rights to commercialize Ryaltris olopatadine hydrochloride/mometasone furoate nasal spray in Australia and… Read more . . .
-
Senzer Ltd has announced plans to launch several inhaled cannabinoid products in the UK, beginning with its Cannafen cannabidiol inhalation solution later this year. Senzer is a subsidiary of Kind Consumer, whose Voke nicotine inhaler… Read more . . .
-
Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko’s Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced… Read more . . .
-
Catalent has announced that it will acquire Juniper Pharma Services (formerly Molecular Profiles) along with its parent company Juniper Pharmaceuticals. Catalent will pay $11.50 per share to acquire all of Juniper Pharmaceuticals’ stock. Juniper Pharmaceuticals… Read more . . .
-
Menarini Asia-Pacific Holdings has signed a multi-year licensing agreement with Orion Corporation for distribution and commercialization of Easyhaler DPI products in China, Hong Kong, Philippines, Malaysia, Indonesia, Thailand, Singapore, Vietnam, Taiwan, and South Korea, the… Read more . . .
-
Swedish DPI developer Iconovo has announced a manufacturing, sales, and distribution agreement with Stevanato Group for its ICOcap dry powder inhaler. The capsule-based ICOcap device will be manufactured by Stevanato Group subsidiary Balda. According to… Read more . . .
-
Posted on OINDPnews on June 29, 2018. Company: Aurobindo Pharma USA, Inc. Status: Full time Location: 2929 Weck Drive, Durham, NC 27703 Description In this role, you will be designing and independently conducting studies in… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland